This is WashU Innovation
The Office of Technology Management assists WashU faculty in the transfer of technology from the lab to the global marketplace.
Explore our innovation community
Needlemans commit $15 million to boost drug discovery
A generous gift from longtime benefactors of Washington University School of Medicine in St. Louis establishes the Needleman Program for Innovation and Commercialization. For a select number of projects, the new program will provide funding to help move promising therapeutics towards the stage where the Food and Drug Administration grants investigational new drug (IND) status.
Sonobiopsies generate genetic, molecular data to inform treatment decisions for brain diseases
The National Institutes of Health (NIH) is channeling $50.3 million over the next five years into a new consortium dedicated to advancing the generation and analysis of multi-omics data for human health research. As part of this team, Washington University in St. Louis is establishing and will lead a central production center that functions as a hub for multi-omics analyses for materials from consortium members at each of six disease study sites identified by the NIH.
Scientists at Washington University in St. Louis have developed a breath test that quickly identifies those who are infected with the virus that causes COVID-19. The device requires only one or two breaths and provides results in less than a minute.
Resources for Students & Alumni
The Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship serves as the primary resource for students and alumni.